68 related articles for article (PubMed ID: 8055404)
1. Amyotrophic lateral sclerosis: is excitotoxicity the key?
Krueger G
CMAJ; 1994 Aug; 151(4):441-3. PubMed ID: 8055404
[No Abstract] [Full Text] [Related]
2. Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonist be used in amyotrophic lateral sclerosis?
Blin O
Adv Neurol; 1995; 68():259-61. PubMed ID: 8787238
[No Abstract] [Full Text] [Related]
3. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
4. [D-serine in the pathogenesis of amyotrophic lateral sclerosis].
Sasabe J; Aiso S
Seikagaku; 2010 Jul; 82(7):628-32. PubMed ID: 20715576
[No Abstract] [Full Text] [Related]
5. [Electrophoresis of blood proteins in amyotrophic lateral sclerosis. (Study on amyotrophic lateral sclerosis XV)].
Sercl M; Kovarík J; Jícha J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(1):Suppl:107-11. PubMed ID: 5229679
[No Abstract] [Full Text] [Related]
6. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
Siklós L; Engelhardt J; Harati Y; Smith RG; Joó F; Appel SH
Ann Neurol; 1996 Feb; 39(2):203-16. PubMed ID: 8967752
[TBL] [Abstract][Full Text] [Related]
7. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
Rothstein JD
Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.
Drachman DB; Rothstein JD
Ann Neurol; 2000 Nov; 48(5):792-5. PubMed ID: 11079544
[TBL] [Abstract][Full Text] [Related]
9. The mRNA expression of AMPA type glutamate receptors in the primary motor cortex of patients with amyotrophic lateral sclerosis: an in situ hybridization study.
Petri S; Krampfl K; Hashemi F; Schmalbach S; Grothe C; Hori A; Dengler R; Bufler J
Neurosci Lett; 2004 Apr; 360(3):170-4. PubMed ID: 15082160
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements.
Whitehouse PJ; Wamsley JK; Zarbin MA; Price DL; Kuhar MJ
Ann Neurol; 1985 May; 17(5):518. PubMed ID: 2988415
[No Abstract] [Full Text] [Related]
11. Excitotoxic blocking strategies in amyotrophic lateral sclerosis.
Hugon J
Adv Neurol; 1995; 68():245-52; discussion 253-8. PubMed ID: 8787237
[No Abstract] [Full Text] [Related]
12. [Etiological drug therapy for amyotrophic lateral sclerosis].
Cintas P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
[TBL] [Abstract][Full Text] [Related]
13. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
Murata T; Ohtsuka C; Terayama Y
J Neurol Sci; 2008 Apr; 267(1-2):66-9. PubMed ID: 17961597
[TBL] [Abstract][Full Text] [Related]
14. Amino acid studies in amyotrophic lateral sclerosis. Preliminary results.
Poser CM; Bunch LM; Johnson M
Trans Am Neurol Assoc; 1964; 89():245-6. PubMed ID: 5828514
[No Abstract] [Full Text] [Related]
15. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
16. Abnormally high levels of SOD1 mRNA in a patient with amyotrophic lateral sclerosis.
Conforti FL; Magariello A; Mazzei R; Sprovieri T; Patitucci A; Crescibene L; Bastone L; Gabriele A; Scornaienchi M; Ferraro T; Muglia M; Quattrone A
Muscle Nerve; 2004 Apr; 29(4):610-1. PubMed ID: 15052629
[No Abstract] [Full Text] [Related]
17. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
[TBL] [Abstract][Full Text] [Related]
18. Abnormal EAAT2 splicing in amyotrophic lateral sclerosis.
Collier DA
Mol Psychiatry; 1998 Jul; 3(4):298. PubMed ID: 9702736
[No Abstract] [Full Text] [Related]
19. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
Waxman EA; Lynch DR
Neuroscientist; 2005 Feb; 11(1):37-49. PubMed ID: 15632277
[TBL] [Abstract][Full Text] [Related]
20. What's the excitement about excitatory amino acids in amyotrophic lateral sclerosis?
Young AB
Ann Neurol; 1990 Jul; 28(1):9-11. PubMed ID: 2375640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
